Correlation Between Lyra Therapeutics and Recursion Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Lyra Therapeutics and Recursion Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lyra Therapeutics and Recursion Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lyra Therapeutics and Recursion Pharmaceuticals, you can compare the effects of market volatilities on Lyra Therapeutics and Recursion Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lyra Therapeutics with a short position of Recursion Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lyra Therapeutics and Recursion Pharmaceuticals.
Diversification Opportunities for Lyra Therapeutics and Recursion Pharmaceuticals
0.35 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Lyra and Recursion is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding Lyra Therapeutics and Recursion Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Recursion Pharmaceuticals and Lyra Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lyra Therapeutics are associated (or correlated) with Recursion Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Recursion Pharmaceuticals has no effect on the direction of Lyra Therapeutics i.e., Lyra Therapeutics and Recursion Pharmaceuticals go up and down completely randomly.
Pair Corralation between Lyra Therapeutics and Recursion Pharmaceuticals
Given the investment horizon of 90 days Lyra Therapeutics is expected to under-perform the Recursion Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Lyra Therapeutics is 1.82 times less risky than Recursion Pharmaceuticals. The stock trades about -0.4 of its potential returns per unit of risk. The Recursion Pharmaceuticals is currently generating about -0.08 of returns per unit of risk over similar time horizon. If you would invest 795.00 in Recursion Pharmaceuticals on November 6, 2024 and sell it today you would lose (71.00) from holding Recursion Pharmaceuticals or give up 8.93% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Lyra Therapeutics vs. Recursion Pharmaceuticals
Performance |
| Timeline |
| Lyra Therapeutics |
| Recursion Pharmaceuticals |
Lyra Therapeutics and Recursion Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Lyra Therapeutics and Recursion Pharmaceuticals
The main advantage of trading using opposite Lyra Therapeutics and Recursion Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lyra Therapeutics position performs unexpectedly, Recursion Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Recursion Pharmaceuticals will offset losses from the drop in Recursion Pharmaceuticals' long position.| Lyra Therapeutics vs. CytomX Therapeutics | Lyra Therapeutics vs. Assembly Biosciences | Lyra Therapeutics vs. Achilles Therapeutics PLC | Lyra Therapeutics vs. Instil Bio |
| Recursion Pharmaceuticals vs. Absci Corp | Recursion Pharmaceuticals vs. Affimed NV | Recursion Pharmaceuticals vs. Sana Biotechnology | Recursion Pharmaceuticals vs. Relay Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |